Gene therapy injection aims to save sight in rare eye disease
Disease control
Recruiting now
This study tests a gene therapy called AAVB-039 for Stargardt disease, an inherited condition that causes vision loss. About 75 adults with a specific gene mutation will receive a single injection under the retina. The main goal is to check safety, but researchers will also measu…
Phase: PHASE1, PHASE2 • Sponsor: AAVantgarde Bio Srl • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC